These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6462008)

  • 1. [Physiological disposition of changrolin (author's transl)].
    Zeng YL; Yi QC; Gu HM; Qu ZX; Xu GY
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):177-81. PubMed ID: 6462008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intracellular distribution of changrolin (author's transl)].
    Tu ZH; Chen EH; Wu WW; Yang HH
    Yao Xue Xue Bao; 1979; 14(10):594-7. PubMed ID: 539425
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoradiographic studies on the distribution of [14C]changrolin in mice].
    Chen WZ; Dong YL; Ding RQ; Zhang X
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):54-5. PubMed ID: 2945385
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on a new antiarrhythmic drug changrolin-4-(3',5'-bis [(N-pyrrolidinyl) methyl]-4'-hydroxyanilino)-quinazoline.
    Li LQ; Qu ZX; Wang ZM; Zeng YL; Ding GS; Hu GJ; Yang XY
    Sci Sin; 1979 Oct; 22(10):1220-8. PubMed ID: 515728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of antiarrhythmic effects of intravenous injections of changrolin and BL-4712A(author's transl)].
    Wang CG; Wang ZM; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):29-31. PubMed ID: 6211899
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on drugs for coronary diseases. II. Synthesis of compounds related to changrolin as potential antiarrhythmic drugs (author's transl)].
    Sun CJ; Zhang XY; Yang XZ; Wang PP; Shen J; Shu Y; Ji RY
    Yao Xue Xue Bao; 1981 Aug; 16(8):564-70. PubMed ID: 7324955
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of antiarrhythmic drug changrolin on myocardial contractility in anesthetized dogs (author's transl)].
    Shen YT; Wu PM; Wan FT; Chen WZ; Dong YL
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):23-6. PubMed ID: 6461194
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)].
    Qu ZX; Cao CY; Zhuang YH
    Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of antiarrhythmia drugs].
    Pastelín G; Sánchez VJ; Vásquez R
    Arch Inst Cardiol Mex; 1981; 51(1):21-9. PubMed ID: 7212854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of propranolol, the beta-adrenergic receptor blocking agents (author's transl)].
    Lou YQ
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):167-70. PubMed ID: 7313673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia].
    Gu CG; Chen WZ; Dong YL; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):173-7. PubMed ID: 6239508
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption, distribution, and excretion of fluproquazone in several animal species.
    Williams JI; Bhuta SI; Jaffe JM; Migdalof BH; Schwarz HJ; Talbot KC; Brouillard JF; Donatsch P; Hodel C; Lemaire M; Meier J; Schweitzer A
    Arzneimittelforschung; 1981; 31(5a):897-904. PubMed ID: 6973983
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.
    Grebow P; Feeney W; Johnston M; Lettieri J; Li H; Magnien E; O'Brien P; Swillo R; Weinryb I; Wolf P; Marsiglia JC
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):407-21. PubMed ID: 7268191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic analysis of changrolin in dogs with arrhythmia.
    Liu CX; Gu YB; Feng JL; Wei GL; Xiao SH; Sun JL
    Yao Xue Xue Bao; 1996; 31(9):666-70. PubMed ID: 9863232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effect.
    Lindstrom TD; Murphy PJ; Smallwood JK; Wiest SA; Steinberg MI
    J Pharmacol Exp Ther; 1982 Jun; 221(3):584-9. PubMed ID: 7086672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the absorption, distribution and excretion of 14C-gossypol in four species of animals (author's transl)].
    Tang XC; Zhu MK; Shi QX
    Yao Xue Xue Bao; 1980 Apr; 15(4):212-7. PubMed ID: 6779501
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15889) in rats.
    Klotz U; Golbs E
    Arzneimittelforschung; 1980; 30(4):619-21. PubMed ID: 7190402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM; Lavis A; Breekpot F
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative kinetics of sematilide in four species.
    Hinderling PH; Dilea C; Koziol T; Millington G
    Drug Metab Dispos; 1993; 21(4):662-9. PubMed ID: 8104126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of Morocromen in animals and man (author's transl)].
    Dell HD; Jacobi H; Kamp R; Lorenz D
    Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.